Navigation Links
K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business
Date:8/8/2011

e suspension of shipments, and related costs;

(26) the ability to sell or license certain assets, and the purchase prices, milestones, terms and conditions of such transactions;

(27) the possibility that default on one type or class of the Company's indebtedness could result in cross default under, and the acceleration of, its other indebtedness;

(28) the risks that present or future changes in the Board of Directors or management may lead to an acceleration of the Company's bonds or to adverse actions by government agencies or our auditors;

(29) the risk that even though the price and 30-day average price of the Company's Class A Common Stock and Class B Common Stock currently satisfy the quantitative listing standards of the New York Stock Exchange, including with respect to minimum share price and public float, the Company can provide no assurance that they will remain at such levels thereafter;

(30) compliance with debt covenants; and

(31) the risks detailed from time-to-time in the Company's filings with the SEC.

This discussion is not exhaustive, but is designed to highlight important factors that may impact the Company's forward-looking statements. Because the factors referred to above, as well as the statements included under the captions Part I, Item 1A -- "Risk Factors," Part II, Item 7 -- "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in the Company's 2011 Form 10-K, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by the Company or on the Company's behalf, you should not place undue reliance on any forward-looking statements.

All forward-looking statements attributable to the Company are expressly qualified in their entirety by the cautionary statements in this "Cautionary Note Regarding Forward-Looking Statements" and the
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  BioLife Solutions, Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues ("BioLife" or the "Company"), announced that ... MicroCap Conference. The Company is scheduled to ... May 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx Biopharmaceuticals, ... on tissue protection, repair and regeneration, today announced that ... is scheduled to present a corporate overview at two ... present at the SeeThruEquity 4 th Annual Microcap ... New York City at 11:00 am EDT. ...
(Date:5/22/2015)... -- According to a new market research ... Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species ... Users - Global Forecast to 2020", published by MarketsandMarkets, the ... $736.85 Million by 2020 from $452.36 Million in 2015, ... Browse 71 market data Tables and 90 Figures spread ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... Jan. 20, 2011 Aubrey Inc. – http://www.aubreyinc.com ... and product evaluation phase of its second generation product, ... production and currently available for purchase.  Founder Aubrey Woodroof, ... advance the art once again.  "It is a wonderful ...
... FRANCISCO, Jan. 20, 2011 TheCarrot.com , ... health engagement programs, announced the immediate availability of ... expertise of the University of California at San ... combines proven behavior modification methodology with TheCarrot.com,s award-winning ...
Cached Medicine Technology:Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product 'AWBAT Plus' 2TheCarrot.com Launches Quit Smoking Program 2TheCarrot.com Launches Quit Smoking Program 3
(Date:5/22/2015)... 2015 Combination therapy, or polytherapy, ... chronic obstructive pulmonary disorder (COPD) as the dominant ... plc as well as Germany’s Boehringer Ingelheim compete ... But will market payers, clinicians and patients be ... to completely new ones? , In spite of ...
(Date:5/22/2015)... Carnegie Science Center and ... new partnership to develop BodyTech, a dynamic, three-pronged health ... includes a new exhibit at the Science Center called ... a new traveling science show, Anatomy Adventure, which will ... , Designed to explore a wide range of topics ...
(Date:5/22/2015)... 22, 2015 Power Systems is proud to ... 2015 race season. Drobeck is in his second year of ... firefighter with the Missoula Fire Department in Missoula, MT. He ... in 2014. During his career, he has had 15 1st ... recorded top 10 finishes in all seven of his 2014 ...
(Date:5/22/2015)... 2015 The dentist in ... that they are now offering complimentary consultations to ... treatments. At consultations, patients can discuss their candidacy ... certain treatments can achieve and whether alternative options ... initial appointment. If treatments are chosen, patients can ...
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
Breaking Medicine News(10 mins):Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... A survey conducted among many Canadian households has revealed ... unable to realize timely medical guidance and facilities,// especially ... ,The Decima poll conducted amongst 3,000 Canadians has shown ... during the previous three months and felt the waiting ...
... Disease Laboratory in Bhopal have finally helped to materialize India's ... H5N1 bird flu virus last month. However, several obstacles lay ... vaccine. ,This is because there is not a ... poultry who has a Bio Safety Level (BSL) 3 lab, ...
... of strategies to combat cervical abnormalities; the worlds first ever ... the market. , ,A feather in the cap ... brain behind this vaccine, who has relentlessly worked on this ... the inaugural shot. This vaccine is powerful in containing the ...
... online interaction between Britain and India, British pupils are ... on various subjects from teachers based in India.// ... one-to-one tuition using Internet telephony from TutorVista, a company ... in shifts. ,While such services have been ...
... awarded a 63-year-old doctor of Indian origin a four-year ... patients over a 13-year //period between September 1991 and ... qualified in India, moved to Britain in 1973. He ... His one-man practice had 2,900 patients. He began his ...
... Board (MPPEB) will hold afresh next month the Dental and ... dental colleges. // ,The test conducted Aug 13 ... probed the complaints cancelled the examination Aug 19. ... examinations in a way so that the results can be ...
Cached Medicine News:Health News:Major Hurdle towards Development of Bird Flu Vaccine in India. 2Health News:British Pupils Opt for Online Tuition from India 2Health News:Indian Doctor in Britain Jailed for Molesting Patients 2
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
... table comes in two modelsthe BT4, which ... BT5, which offers five. With the simple ... to suit your needs. Both models ... side rails, ankle/foot supports, adjustable arm boards, ...
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
5 Part Differential Auto Hematology Analyzer.,Top of the range Cell Counter for medium-sized laboratories....
Medicine Products: